Hill & Smith PLC Allocates 108,418 Shares Under Employee Share Plans in Latest Six-Month Regulatory Filing

About Hill & Smith PLC and Its Employee Share Scheme Structure

Listed on the London Stock Exchange, Hill & Smith PLC operates in engineering and infrastructure sectors, including water infrastructure, transportation, and industrial services across multiple regions. As a FTSE-listed company, it adheres to governance and regulatory frameworks that include employee share schemes aimed at aligning employee interests with shareholder value.

The six-monthly block listing return is a mandatory disclosure under UK Listing Rules, providing transparency on securities issued under employee benefit schemes such as ShareSave, Employee Stock Purchase Plans, and Executive Share Option Schemes. This ensures investors have clear insights into share issuance to employees and remaining authorised securities. Hill & Smith's filing demonstrates compliance with UK financial regulations and corporate governance standards.

Securities Issued in the Reporting Period

Between 22 January 2026 and 21 July 2026, Hill & Smith allotted 108,418 securities to employees participating in its share schemes. This allotment reflects the execution of employee remuneration and incentive plans, including ShareSave scheme maturities, Executive Share Option vesting, and Employee Stock Purchase Plan drawdowns. Disclosure of this figure offers investors clarity on employee share issuance activity.

The issuance of 108,418 securities indicates active employee engagement with the company’s share plans during the first half of 2026. This allotment rate provides investors with quantitative data on share dilution and capital structure impact from employee share schemes, enabling assessment of the ongoing effect on issued share capital.

Unallotted Securities: Opening and Closing Balances

At the start of the period on 22 January 2026, Hill & Smith held 278,180 unallotted securities under its employee share schemes. This represented the authorised but unissued securities available for employee allocation.

By 21 July 2026, the unallotted securities balance decreased to 169,762, reflecting the allotment of 108,418 shares during the period with no new authorisations added. This 38.8% reduction demonstrates significant utilisation of the existing securities pool. The remaining balance indicates the capacity for further employee share issuance under current authorisations.

No Increase in Scheme Authorisation During the Period

The filing confirms Hill & Smith did not seek to increase its block scheme allocation during the six-month period, relying solely on previously authorised securities to meet employee share scheme demands. This suggests the existing authorisation was sufficient or a strategic decision was made not to expand the scheme at this time.

With no new authorisation, the current unallotted securities would sustain approximately 1.6 more six-month periods at the current allotment rate. Investors should note this when evaluating future capital structure changes and potential shareholder approvals for scheme renewals.

Employee Share Scheme Details and Participation

Hill & Smith’s employee share framework includes ShareSave Schemes, Employee Stock Purchase Plans, and Executive Share Option Schemes. ShareSave Schemes allow employees to save and purchase shares at a discount after specified periods, promoting broad employee ownership. Executive Share Option Schemes target senior management with vesting conditions. Employee Stock Purchase Plans enable direct share purchases, sometimes with employer incentives. The combined allotment of 108,418 securities reflects participation across these plans, though specific allocation details were not disclosed.

Regulatory Compliance and UK Listing Rules

The six-monthly block listing return complies with UK Listing Rules section UKLR 20.6.7G, mandating disclosure of securities allotted, unallotted balances, and changes in scheme authorisations. Hill & Smith’s timely submission on 22 July 2026 underscores its commitment to regulatory transparency and governance.

This regulatory framework ensures investor awareness of dilution effects from employee share schemes and confirms that share issuances remain within authorised limits. Contact details for regulatory matters are provided as K L Atterbury, Company Secretary, at 0121 704 7430.

Impact on Share Dilution and Capital Structure

The issuance of 108,418 securities during the period increases Hill & Smith’s issued share capital, with an estimated annualised issuance of approximately 216,836 securities if current rates persist. The overall dilution impact depends on the company’s total issued shares, which were not disclosed here. Investors should cross-reference this data with official share counts to fully assess dilution effects.

As the unallotted securities decrease, the company will eventually need shareholder approval for additional authorisations to continue employee share schemes at current levels. Monitoring the depletion rate offers insights into potential future capital management actions or shareholder meetings related to scheme renewals.

Investor Insights on Employee Share Scheme Administration

The disclosed allotment and unallotted figures provide detailed insights into Hill & Smith’s employee share scheme operations. The substantial allotment indicates strong employee participation, which may be viewed positively for aligning employee and shareholder interests. However, some investors may consider the dilution impact when evaluating the company’s long-term value.

To understand the full implications, investors should consider these figures alongside the company’s broader capital strategy, dividend policies, and financial results. Details on vesting schedules, performance conditions, and participation rates are available in Hill & Smith’s annual reports and remuneration committee disclosures.

Future Outlook and Scheme Capacity

At the current allotment pace, the remaining 169,762 unallotted securities would last for roughly eight months. Hill & Smith may need to seek shareholder approval for scheme expansions or renewals within the next 12 to 18 months to sustain employee participation levels.

No plans for additional authorisations were disclosed in this filing. Investors should monitor future announcements for shareholder resolutions or changes to employee share arrangements. This regulatory disclosure focuses on quantitative data and does not provide forward-looking strategic guidance.